Experimental findings postulate the role of LDHA overexpression‐induced L‐lactate signaling and its interplay with AMPK/mTOR signaling, which may provide scientific evidence for future precision therapy of PAAD. This evidence concerns the gene LDHA and pancreatic adenocarcinoma.